These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24556690)

  • 1. Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism.
    Narayanan SP; Xu Z; Putluri N; Sreekumar A; Lemtalsi T; Caldwell RW; Caldwell RB
    Cell Death Dis; 2014 Feb; 5(2):e1075. PubMed ID: 24556690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration.
    Suwanpradid J; Rojas M; Behzadian MA; Caldwell RW; Caldwell RB
    PLoS One; 2014; 9(11):e110604. PubMed ID: 25375125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginase 2 deletion reduces neuro-glial injury and improves retinal function in a model of retinopathy of prematurity.
    Narayanan SP; Suwanpradid J; Saul A; Xu Z; Still A; Caldwell RW; Caldwell RB
    PLoS One; 2011; 6(7):e22460. PubMed ID: 21811615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen-induced retinopathy induces short-term glial stress and long-term impairment of photoentrainment in mice.
    Mehdi MK; Sage-Ciocca D; Challet E; Malan A; Hicks D
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):595-608. PubMed ID: 24509649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy.
    Wang L; Shi P; Xu Z; Li J; Xie Y; Mitton K; Drenser K; Yan Q
    Invest Ophthalmol Vis Sci; 2014 May; 55(7):4276-87. PubMed ID: 24867581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of aldose reductase attenuates inner retinal neuronal changes in a mouse model of retinopathy of prematurity.
    Fu Z; Nian S; Li SY; Wong D; Chung SK; Lo AC
    Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1503-13. PubMed ID: 25921391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term evaluation of retinal morphology and function in a mouse model of oxygen-induced retinopathy.
    Mezu-Ndubuisi OJ; Macke EL; Kalavacherla R; Nwaba AA; Suscha A; Zaitoun IS; Ikeda A; Sheibani N
    Mol Vis; 2020; 26():257-276. PubMed ID: 32256029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyamine system in developing rat eye and an animal model of retinopathy of prematurity.
    Gralek M; Sasiak K; Wojcik A; Gardiner TA; Fogel WA
    Graefes Arch Clin Exp Ophthalmol; 1999 Sep; 237(9):781-6. PubMed ID: 10447655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis.
    Palani CD; Fouda AY; Liu F; Xu Z; Mohamed E; Giri S; Smith SB; Caldwell RB; Narayanan SP
    Mol Neurobiol; 2019 Dec; 56(12):8589-8602. PubMed ID: 31280447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperoxia causes reduced density of retinal astrocytes in the central avascular zone in the mouse model of oxygen-induced retinopathy.
    Bucher F; Stahl A; Agostini HT; Martin G
    Mol Cell Neurosci; 2013 Sep; 56():225-33. PubMed ID: 23756201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy.
    Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous assessment of aberrant retinal vascularization, thickness, and function in an in vivo mouse oxygen-induced retinopathy model.
    Mezu-Ndubuisi OJ; Adams T; Taylor LK; Nwaba A; Eickhoff J
    Eye (Lond); 2019 Mar; 33(3):363-373. PubMed ID: 30209267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinopathy of prematurity protection conferred by uteroplacental insufficiency through erythropoietin signaling in an experimental Murine Model.
    Fung C; Cung T; Nelson C; Wang H; Bretz C; Ramshekar A; Brown A; Stoddard GJ; Hartnett ME
    Pediatr Res; 2023 Sep; 94(3):950-955. PubMed ID: 37016003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy.
    Deliyanti D; Lee JY; Petratos S; Meyer CJ; Ward KW; Wilkinson-Berka JL; de Haan JB
    Clin Sci (Lond); 2016 Aug; 130(15):1375-87. PubMed ID: 27005782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with polyamine oxidase inhibitor reduces microglial activation and limits vascular injury in ischemic retinopathy.
    Patel C; Xu Z; Shosha E; Xing J; Lucas R; Caldwell RW; Caldwell RB; Narayanan SP
    Biochim Biophys Acta; 2016 Sep; 1862(9):1628-39. PubMed ID: 27239699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17β-estradiol ameliorates oxygen-induced retinopathy in the early hyperoxic phase.
    Zhang H; Wang X; Xu K; Wang Y; Wang Y; Liu X; Zhang X; Wang L; Li X
    Biochem Biophys Res Commun; 2015 Feb; 457(4):700-5. PubMed ID: 25619134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice.
    Brooks SE; Gu X; Samuel S; Marcus DM; Bartoli M; Huang PL; Caldwell RB
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):222-8. PubMed ID: 11133872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A1 Receptors Selectively Modulate Oxygen-Induced Retinopathy at the Hyperoxic and Hypoxic Phases by Distinct Cellular Mechanisms.
    Zhang S; Li H; Li B; Zhong D; Gu X; Tang L; Wang Y; Wang C; Zhou R; Li Y; He Y; Chen M; Huo Y; Liu XL; Chen JF
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8108-19. PubMed ID: 26720463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of thioredoxin interacting protein (TXNIP) augments hyperoxia-induced vaso-obliteration in a mouse model of oxygen induced-retinopathy.
    Abdelsaid MA; Matragoon S; Ergul A; El-Remessy AB
    PLoS One; 2014; 9(10):e110388. PubMed ID: 25329456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional consequences of trolox C treatment in the rat model of postnatal hyperoxia.
    Dorfman AL; Dembinska O; Chemtob S; Lachapelle P
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1101-8. PubMed ID: 16505047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.